Palivizumab prophylaxis of respiratory syncytial virus disease from 1998-2002: Results from four years of palivizumab usage
Romero J. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998-2002: Results from four years of palivizumab usage. Pediatr Infect Dis J. 2003; 22(2):Supp: 46-54.